Implantation of GL261 neurospheres into C57/BL6 mice: A more reliable syngeneic graft model for research on glioma-initiating cells

International Journal of Oncology

Volumn 43, Issue 2, 2013, Pages 477-484

  Yi, Liang ^a   Zhou, Chun ^a,b   Wang, Bing ^c   Chen, Tunan ^b   Xu, Minhui ^a   Xu, Lunshan ^a   Feng, Hua ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c People's Hospital of Yongchuan   (China)

Author keywords

Cancer stem cell; GL261; Glioma; Inflammation

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; NESTIN; NIMUSTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENICITY; CELL RENEWAL; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOGRAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GLIOMA; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TUMOR MICROENVIRONMENT;

EID: 84879611515     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1962     Document Type: Article

References (40)

1. Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
2. Stiles CD and Rowitch DH: Glioma stem cells: a midterm exam. Neuron 58: 832-846, 2008. (Pubitemid 351842757)
3. Singh A and Settleman J: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751, 2010.
4. Sughrue ME, Yang I, Kane AJ, et al: Immunological considerations of modern animal models of malignant primary brain tumors. J Transl Med 7: 84, 2009.
5. Wei J, Barr J, Kong LY, et al: Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther 9: 67-78, 2010.
6. Dziurzynski K, Wei J, Qiao W, et al: Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res 17: 4642-4649, 2011.
7. Pellegatta S, Poliani PL, Corno D, et al: Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66: 10247-10252, 2006. (Pubitemid 44799739)
8. Yu SC, Ping YF, Yi L, et al: Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265: 124-134, 2008.
9. Bao S, Wu Q, Sathornsumetee S, et al: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848, 2006. (Pubitemid 44299144)
10. Maes W and Van Gool SW: Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model. Cancer Immunol Immunother 60: 153-160, 2011.
11. Yi L, Xiao H, Xu M, et al: Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J Neuroimmunol 232: 75-82, 2011.
12. Yi L, Zhou ZH, Ping YF, et al: Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Mod Pathol 20: 1061-1068, 2007. (Pubitemid 47429200)
13. + T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol 89: 85-91, 2011.
14. Beier D, Schulz JB and Beier CP: Chemoresistance of glioblastoma cancer stem cells - much more complex than expected. Mol Cancer 10: 128, 2011.
15. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004. (Pubitemid 39331011)
16. Calabrese C, Poppleton H, Kocak M, et al: A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82, 2007. (Pubitemid 46054518)
17. Krishnamurthy S, Dong Z, Vodopyanov D, et al: Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 70: 9969-9978, 2010.
18. Li Z, Bao S, Wu Q, et al: Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15: 501-513, 2009.
19. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
20. Bayne LJ, Beatty GL, Jhala N, et al: Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21: 822-835, 2012.
21. Charles NA, Holland EC, Gilbertson R, Glass R and Kettenmann H: The brain tumor microenvironment. Glia 59: 1169-1180, 2011.
22. Hussain SF, Yang D, Suki D, Aldape K, Grimm E and Heimberger AB: The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-oncol 8: 261-279, 2006. (Pubitemid 46542651)
23. Wiencke JK, Accomando WP, Zheng S, et al: Epigenetic biomarkers of T-cells in human glioma. Epigenetics 7: 1391-1402, 2012.
24. Hong TM, Teng LJ, Shun CT, Peng MC and Tsai JC: Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J Neurooncol 93: 289-301, 2009.
25. Guryanova OA, Wu QL, Cheng L, et al: Non-receptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19: 498-511, 2011.
26. Lamszus K and Gunther HS: Glioma stem cells as a target for treatment. Target Oncol 5: 211-215, 2010.
27. Chen J, McKay RM and Parada LF: Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149: 36-47, 2012.
28. Li Z, Wang H, Eyler CE, Hjelmeland AB and Rich JN: Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways. J Biol Chem 284: 16705-16709, 2009.
29. Wagers AJ: The stem cell niche in regenerative medicine. Cell Stem Cell 10: 362-369, 2012.
30. Ginestier C, Liu S, Diebel ME, et al: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120: 485-497, 2010.
31. Sansone P, Storci G, Tavolari S, et al: IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117: 3988-4002, 2007. (Pubitemid 350224108)
32. Weiss WA, Burns MJ, Hackett C, et al: Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res 63: 1589-1595, 2003. (Pubitemid 36373648)
33. Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M and Holland EC: mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7: 356-368, 2005. (Pubitemid 40664225)
34. Szatmari T, Lumniczky K, Desaknai S, et al: Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97: 546-553, 2006. (Pubitemid 43811598)
35. Hatiboglu MA, Wei J, Wu AS and Heimberger AB: Immune therapeutic targeting of glioma cancer stem cells. Target Oncol 5: 217-227, 2010.
36. Wei J, Barr J, Kong LY, et al: Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res 16: 461-473, 2010.
37. Ausman JI, Shapiro WR and Rall DP: Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res 30: 2394-2400, 1970.
38. Daga A, Orengo AM, Gangemi RM, et al: Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses. Int J Cancer 121: 1756-1763, 2007. (Pubitemid 47417294)
39. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J and Bernier G: BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29: 8884-8896, 2009.
40. Kim R, Emi M and Tanabe K: Cancer immunoediting from immune surveillance to immune escape. Immunology 121: 1-14, 2007. (Pubitemid 46537674)